GPP
Great Point Partners’s Relmada Therapeutics RLMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-510,000
| Closed | -$18.9M | – | 52 |
|
|
2022
Q3 | $18.9M | Sell |
510,000
-190,000
| -27% | -$7.03M | 4.55% | 9 |
|
|
2022
Q2 | $13.3M | Sell |
700,000
-90,000
| -11% | -$1.71M | 3.19% | 12 |
|
|
2022
Q1 | $21.3M | Buy |
790,000
+72,680
| +10% | +$1.96M | 5.15% | 11 |
|
|
2021
Q4 | $16.2M | Buy |
+717,320
| New | +$16.2M | 3.59% | 9 |
|